Cargando…

Functional characterization of GM-CSF induced monocyte subsets

Detalles Bibliográficos
Autores principales:	Däbritz, J, Ehrchen, J, Wittkowski, H, Barczyk, K, Roth, J, Foell, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333921/ http://dx.doi.org/10.1186/1546-0096-6-S1-P125

Ejemplares similares

PReS-FINAL-2332: Activation-induced cell death of human monocytes as a novel mechanism fine-tuning inflammation and autoimmunity
por: Miranda-García, M, et al.
Publicado: (2013)

The Damage Associated Molecular Pattern (DAMP) molecule S100A12 induces pro-inflammatory responses in monocytes via innate immunity signalling pathways
por: Wittkowski, H, et al.
Publicado: (2008)

PW03-031 – Activation-induced cell death of human monocytes
por: Miranda-Garcia, M, et al.
Publicado: (2013)

Diagnostic value of 18F-FDG-PET and PET-CT in children with fever of unknown origin or unexplained signs of inflammation
por: Däbritz, J, et al.
Publicado: (2008)

The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis
por: Frosch, M, et al.
Publicado: (2008)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn’s disease
por: Däbritz, Jan
Publicado: (2015)

The anti-inflammatory stage of monocytes after long-term stimulation with LPS is mediated by p38 MAP kinase dependent epigenetic silencing
por: Viemann, D, et al.
Publicado: (2008)

More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages
por: Ehrchen, Jan M., et al.
Publicado: (2019)

Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEX(mGM-CSF)
por: Cooke, Keegan, et al.
Publicado: (2015)

Evaluation of the effect of GM-CSF blocking on the phenotype and function of human monocytes
por: Lotfi, Noushin, et al.
Publicado: (2020)

The phagocyte specific protein S100A12 as a novel biomarker in Muckle-Wells-Syndrome before and during therapy with Anakinra and Canakinumab (ACZ885)
por: Wittkowski, H, et al.
Publicado: (2008)

HLA-DR expression on monocytes and the T-cell subset in septic patients
por: Menestrina, N, et al.
Publicado: (2005)

Monocyte subset recruitment to the peritoneum following abdominal surgical incision in mice
por: Bunker, N, et al.
Publicado: (2011)

Peripheral Monocyte Functions and Activation in Patients with Quiescent Crohn’s Disease
por: Schwarzmaier, David, et al.
Publicado: (2013)

GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis
por: Shi, Hui, et al.
Publicado: (2020)

Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 gag
por: Qiu, Jian-Tai, et al.
Publicado: (2006)

PReS-FINAL-2340: A pathogenic role for S100A8/A9 in experimental autoimmune arthritis
por: Kessel, C, et al.
Publicado: (2013)

The addition of granulocyte macrophage colony stimulating factor (GM-CSF) to juvenile systemic lupus erythematosus serum can reduce abnormal neutrophil apoptosis
por: Midgley, AJ, et al.
Publicado: (2008)

Pre-operative intradermal administration of CpG-B ± GM-CSF in stage I-III melanoma patients arms the sentinel lymph node: evidence for reduced tumor spread
por: van den Hout, Mari F, et al.
Publicado: (2013)

PReS-FINAL-2069: T cells secreting granulocyte-macrophage colony stimulating factor (GM-CSF) within the inflammed joint originate from an "EX-Th17" population
por: Nistala, K, et al.
Publicado: (2013)

GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
por: Robinson, H, et al.
Publicado: (2012)

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
por: Greene, Julia, et al.
Publicado: (2014)

GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function
por: Sun, Li, et al.
Publicado: (2018)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis
por: Joshi, Ila, et al.
Publicado: (2023)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

Perspectives for the allergenicity assessment of key allergens in GM plants
por: Fernandez, A, et al.
Publicado: (2013)

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
por: Greene, Julia, et al.
Publicado: (2014)

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine
por: Jackson, Doreen, et al.
Publicado: (2015)

GM-CSF production by non-classical monocytes controls antagonistic LPS-driven functions in allergic inflammation
por: Kaur, Kamaljeet, et al.
Publicado: (2021)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
por: Hilton, Traci, et al.
Publicado: (2014)

MRI Visualization of CSF Flow
por: Melamed, Edward Frederick, et al.
Publicado: (2015)

PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany
por: Gohar, F, et al.
Publicado: (2013)

Th1 is the predominant helper T cell subset that produces GM-CSF in the joint of rheumatoid arthritis
por: Yamada, Hisakata, et al.
Publicado: (2017)

GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family
por: Lutz, Manfred B., et al.
Publicado: (2017)

Phase III randomized, double-blinded, placebo-controlled multicenter trial of melapuldencil-t: autologous dendritic cells loaded with irradiated autologous tumor cells (dc-tc) in gm-csf in patients with metastatic melanoma
por: Dillman, Robert, et al.
Publicado: (2014)

Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials
por: de Gruijl, Tanja D, et al.
Publicado: (2015)

Vaccination with MVA/HIV induces differential recruitment of monocyte subsets into the circulation and monocyte-specific transcriptional programs
por: Andersen-Nissen, E, et al.
Publicado: (2012)

Preliminary analysis of immune responses in patients enrolled in a Phase II trial of cyclophosphamide with allogenic dribble vaccine alone (DPV-001) or with GM-CSF or imiquimod for adjuvant treatment of stage IIIa or IIIb NSCLC
por: Sanborn, Rachel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0mears3s9fjohjlns01vofkkrm